Two new publicly traded orthopedic device companies are expected to enter the market in 2022, according to announcements from Zimmer Biomet and Colfax Corp. in the last month:
1. Zimmer Biomet plans to spin off its spine and dental units to create two independent companies. Zimmer Biomet will focus on orthopedics and NewCo will be dedicated to spine and dental. The company decided to spin off the dental and spine lines because they include similar implant materials and scalability prospects. The transaction is expected to close in mid-2022.
2. Industrial equipment manufacturer Colfax plans to split its medical device business, DJO, and its industrial business, ESAB, into two companies. DJO, acquired by Colfax for $3.2 billion in 2019, develops products for joint reconstruction, vascular health and pain management. The device company will be renamed before the split to reflect its strategic focus.